Treatment of primary graft dysfunction after lung transplantation

  • Slides: 4
Download presentation
Treatment of primary graft dysfunction after lung transplantation with orally inhaled AP 301: A

Treatment of primary graft dysfunction after lung transplantation with orally inhaled AP 301: A prospective, randomized pilot study Clemens Aigner, MD, MBA, Alexis Slama, MD, Maximilian Barta, MD, Andreas Mitterbauer, MD, Gyoergy Lang, MD, Ph. D, Shahrokh Taghavi, MD, Jose Matilla, MD, Roman Ullrich, MD, Katharina Krenn, MD, Peter Jaksch, MD, Klaus Markstaller, MD, Walter Klepetko, MD The Journal of Heart and Lung Transplantation Volume 37 Issue 2 Pages 225 -231 (February 2018) DOI: 10. 1016/j. healun. 2017. 09. 021 Copyright © 2018 International Society for the Heart and Lung Transplantation Terms and Conditions

Figure 1 The Journal of Heart and Lung Transplantation 2018 37225 -231 DOI: (10.

Figure 1 The Journal of Heart and Lung Transplantation 2018 37225 -231 DOI: (10. 1016/j. healun. 2017. 09. 021) Copyright © 2018 International Society for the Heart and Lung Transplantation Terms and Conditions

Figure 2 The Journal of Heart and Lung Transplantation 2018 37225 -231 DOI: (10.

Figure 2 The Journal of Heart and Lung Transplantation 2018 37225 -231 DOI: (10. 1016/j. healun. 2017. 09. 021) Copyright © 2018 International Society for the Heart and Lung Transplantation Terms and Conditions

Figure 3 The Journal of Heart and Lung Transplantation 2018 37225 -231 DOI: (10.

Figure 3 The Journal of Heart and Lung Transplantation 2018 37225 -231 DOI: (10. 1016/j. healun. 2017. 09. 021) Copyright © 2018 International Society for the Heart and Lung Transplantation Terms and Conditions

Corneal Graft Rejection and Graft Failure CORNEAL GRAFTCorneal Graft Rejection and Graft Failure CORNEAL GRAFT
Primary graft dysfunction and other selected complications ofPrimary graft dysfunction and other selected complications of
LUNG TRANSPLANTATION Overall ISHLT 2003 J Heart LungLUNG TRANSPLANTATION Overall ISHLT 2003 J Heart Lung